Vaxart Stock

Vaxart Gross Margin

The Gross Margin of Vaxart (VXRT) as of Aug 19, 2026 is 100.00 %. In the previous year, Gross Margin was 100.00 % — a change of 0.00% (lower).

Gross Margin

100.00 %

YoY

0.00%

Last updated:

Gross Margin of Vaxart is 2026 100.00 % . Gross Margin of Vaxart was 2025 100.00 % . It decreases by 0.00% lower compared to the previous year.

For Vaxart, the gross margin of 100.0% is up versus -5,365.1% a few years ago.

Access this data via the Eulerpool API

Vaxart Stock analysis

What does Vaxart do? Vaxart Inc is a US biotechnology company that was founded in 2004 and is based in South San Francisco, California. The company specializes in the development of oral vaccines and therapeutics. Vaxart is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vaxart stock

Gross Margin of Vaxart is 100.00 % in 2026.

Gross Margin of Vaxart changed from 100.00 % to 100.00 %, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Vaxart since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Vaxart with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Vaxart

All Key Metrics — Vaxart